Search Results 791-800 of 16991 for pharmacogenetics
This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...
Learn about causes and treatment of this blood disorder that mainly affects women and may cause blood clots and miscarriages.
Mayo Clinic researchers uncover new agents that eliminate cells associated with age-related diseases featured · Mayo Clinic researchers identify therapy that ...
About this study. The purpose of this study is to determine the safety profile and the maximum dose of Debio 1143 (AT-406) that can be given to humans.
About this study. Does tranexamic acid improve the perioperative care of those patients treated surgically for hip fracture by decreasing the proportion of ...
Mayo Clinic's Division of Gastroenterology and Hepatology offers treatment and specialty care for people with a wide range of rare and common digestive ...
This phase II trial studies how well olaparib works in treating patients with biliary tract cancer that has spread to other places in the body (metastatic) and ...
ROCHESTER, Minn. — Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns linked ...
Focus areas of the Lipid Homeostasis and Neurobiology in Aging and Dementias Lab include: Apolipoprotein E (APOE) and cerebrovascular functions in Alzheimer's ...
The purpose of this study is to see how well lorvotuzumab mertansine works in treating younger patients with Wilms tumor, rhabdomyosarcoma, neuroblastoma, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.